Skip to main content

Table 2 Correlations of serum nesfatin-1 with clinical and biochemical parameters among studied patients groups and healthy control

From: Serum nesfatin-1 is a biomarker of pre-diabetes and interplays with cardiovascular risk factors

 

Diabetic group (n = 30)

Pre-diabetic group (n = 30)

Healthy subjects (n = 28)

r

P

r

P

r

P

Age (years)

0.032

0.868

− 0.240

0.200

0.060

0.755

Waist circumference (cm)

− 0.285

0.126

0.203

0.283

0.054

0.779

Waist/ hip ratio

0.295

0.114

0.094

0.622

− 0.027

0.889

Body mass index (kg/m2)

0.221

0.241

− 0.178

0.346

− 0.265

0.157

Systolic blood pressure (mmHg)

− 0.490

0.006*

− 0.531

0.003*

− 0.127

0.505

Diastolic blood pressure (mmHg)

− 0.033

0.864

0.339

0.067

0.170

0.369

Fasting plasma glucose (mg/dl)

− 0.619

< 0.001*

− 0.454

0.012*

− 0.095

0.618

2hPP plasma glucose (mg/dl)

− 0.390

0.033*

− 0.523

0.003*

− 0.226

0.229

Hemoglobin A1c(%)

− 0.447

0.013*

− 0.601

< 0.001*

− 0.239

0.203

Fasting insulin (μU/mL

− 0.515

0.004*

− 0.569

0.001*

0.128

0.499

HOMA-IR

− 0.406

0.026*

− 0.428

0.018*

0.162

0.392

Total cholesterol (mg/dl)

− 0.549

0.002*

− 0.440

0.015*

− 0.279

0.136

Triglycerides (mg/dl)

− 0.503

0.005*

− 0.518

0.003*

− 0.242

0.197

High-density lipoprotein (mg/dl)

0.573

0.001*

0.562

0.001*

0.265

0.156

Low-density lipoprotein (mg/dl)

− 0.419

0.021*

− 0.543

0.002*

− 0.298

0.109

  1. HOMA-IR = homeostasis model assessment of insulin resistance; correlation by Pearson coefficient significant difference at p value < 0.05, r correlation coefficient weak (r = 0–0.24), fair (r = 0.25–0.49), moderate (r = 0.5–0.74), strong (r = 0.75-1)